Kenji Kuramoto
Chairman at PHOENIXBIO CO., LTD.
Net worth: 106 473 $ as of 29/04/2024
Profile
Kenji Kuramoto is currently the Chairman at PhoenixBio Co., Ltd.
He previously held the position of Chairman at PhoenixBio USA Corp.
Additionally, he served as the President & Representative Director at Institute of Immunology Co., Ltd.
and as the Manager-Corporate Planning at Sanwa Starch Co., Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHOENIXBIO CO., LTD.
0.87% | 30/03/2023 | 35,200 ( 0.87% ) | 106 473 $ | 29/04/2024 |
Kenji Kuramoto active positions
| Companies | Position | Start |
|---|---|---|
| PHOENIXBIO CO., LTD. | Chairman | 27/06/2018 |
Former positions of Kenji Kuramoto
| Companies | Position | End |
|---|---|---|
Institute of Immunology Co., Ltd.
 Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | President | 31/12/2005 |
PhoenixBio USA Corp.
 PhoenixBio USA Corp. Miscellaneous Commercial ServicesCommercial Services Part of PhoenixBio Co., Ltd., PhoenixBio USA Corp. develops technologies for mass propagation of human cells into laboratory animals. The company is based in New York, NY. Yoshio Morikawa has been the CEO of the company since 2015. | Chairman | - |
Sanwa Starch Co., Ltd.
 Sanwa Starch Co., Ltd. Agricultural Commodities/MillingProcess Industries Sanwa Starch Co., Ltd. manufactures and processes starch and starch products. The firm also manufactures sugar and glucose-based products. The company was founded by Seiichi Morimoto on January 9, 1947 and is headquartered in Kashihara, Japan. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Sanwa Starch Co., Ltd.
Sanwa Starch Co., Ltd. Agricultural Commodities/MillingProcess Industries Sanwa Starch Co., Ltd. manufactures and processes starch and starch products. The firm also manufactures sugar and glucose-based products. The company was founded by Seiichi Morimoto on January 9, 1947 and is headquartered in Kashihara, Japan. | Process Industries |
Institute of Immunology Co., Ltd.
Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Health Technology |
| PhoenixBio Co., Ltd. | |
PhoenixBio USA Corp.
PhoenixBio USA Corp. Miscellaneous Commercial ServicesCommercial Services Part of PhoenixBio Co., Ltd., PhoenixBio USA Corp. develops technologies for mass propagation of human cells into laboratory animals. The company is based in New York, NY. Yoshio Morikawa has been the CEO of the company since 2015. | Commercial Services |
- Stock Market
- Insiders
- Kenji Kuramoto
